Acetic Acid Supplementation: Effect on Resting and Exercise Energy Expenditure and Substrate Utilization.

The purpose of this study was to investigate the influence of acetic acid (apple cider vinegar; ACV) supplementation on resting and exercise energy expenditure and substrate utilization. Using a randomized, double blind, crossover design, 16 healthy subjects were supplemented for 4 d with either ACV (30-ml/d) mixed in 1 L of a non-nutritive lemon-flavored drink or a placebo (PLA). They were then assessed via indirect calorimetry for resting energy expenditure (REE) and substrate utilization. This was immediately followed by the assessment of steady state cycling exercise energy expenditure at 40 W (EEE-40) and 80 W (EEE-80) and substrate utilization. Results: Neither REE nor resting substrate utilization were significantly different between groups (p ≥ .05). During cycling exercise at both 40W and 80W, there were no significant differences observed between groups for energy expenditure (EEE-40: ACV 4.13 ± 0.79, PLA 4.37 ± 0.61 kcal/min; EEE-80: ACV 6.09 ± 0.87, PLA 6.26 ± 0.72 kcal/min) or substrate utilization (40W carbohydrate: ACV 0.72 ± 0.19, PLA 0.76 ± 0.16; fat: ACV 0.15 ± 0.07, PLA 0.16 ± 0.06 g/min), (80W carbohydrate: ACV 1.28 ± 0.32, PLA 1.34 ± 0.35; fat: ACV 0.14 ± 0.10, PLA 0.14 ± 0.10 g/min) (p ≥ .05). Conclusions: Recent findings suggest that chronic acetic acid supplementation is associated with significant reductions in body weight and body fat; however, the findings of the present study suggest that a semi-acute (4 d) acetic acid supplementation does not impact resting or exercise energy expenditure or substrate utilization.

Dark Chocolate Supplementation Elevates Resting Energy Expenditure in Exercise Trained Females.

Several recent reports have indicated positive health and exercise benefits of (-)-epicatechin-rich cocoa products. This study investigated the influence of dark chocolate (DC) supplementation on resting and steady state exercise metabolism in a group of athletically fit females. Using a randomized, single-blind design, 18 exercise trained female subjects were assigned to a 30-d supplementation with either 20g · d-1 of 70% DC (n = 9) or a calorically matched white chocolate (WC) (n = 9). Pre-supplementation (PRE), subjects underwent indirect calorimetry assessment for resting energy expenditure (REE) and exercise energy expenditure (EEE) consisting of steady state cycling for 20 min, 10 min each at 50 W (EEE-50) and 100 W (EEE-100). Upon completion of the 30-d supplementation (POST), subjects repeated the assessment for REE, EEE-50, and EEE-100. Post supplementation REE was significantly increased by ~9.6% in the DC group (Δ REE: DC 140 ± 132, WC -3 ± 92 kcal · d-1, p = .017). Post supplementation, neither EEE-50 (DC 4.51 ± 0.59, WC 4.51 ± 0.32 kcal · min-1) nor EEE-100 (DC 6.56 ± 0.60, WC 6.69 ± 0.42 kcal · min-1) were significantly different between groups (p ≥ .05). There were no significant within or between group time effects for substrate utilization at rest or during EEE-50 or EEE-100 (p ≥ .05). To our knowledge this is the first study to demonstrate that a relatively small daily dosage of DC can significantly elevate REE. However, it does not impact steady state EEE or substrate utilization in a group of athletically fit females.

Six weeks of oral Echinacea purpurea supplementation does not enhance the production of serum erythropoietin or erythropoietic status in recreationally active males with above-average aerobic fitness.

The purpose of this study was to investigate the effect of 6 weeks of oral Echinacea purpurea supplementation on serum erythropoietin (EPO) and erythropoietic status. Twenty-four males (mean ± SE; age = 25.2 ± 1.4 years, height = 178.1 ± 1.4 cm, body mass = 78.1 ± 1.6 kg, body fat = 12.7 ± 0.9%, maximal oxygen uptake = 52.9 ± 0.9 mL·kg-1·min-1) were randomly grouped using a matched-pair, double-blind design and self-administered 8000 mg·day-1 of either E. purpurea (n = 12) or placebo (n = 12) for 42 consecutive days. Blood samples were collected prior to supplementation (day 0) and every 2 weeks during the supplementation period (days 14, 28, and 42) and were analyzed for EPO, red blood cell count, hemoglobin concentration, hematocrit, mean corpuscular volume, and mean corpuscular hemoglobin concentration. Separate 2 × 4 (group × time) factorial ANOVA with repeated measures on time were used to determine statistical differences with significance set at p ≤ 0.05. There were no significant interaction, group, or time effects observed for EPO or erythropoietic status markers for any of the measurement points (p ≤ 0.05). The present study indicated that 6 weeks of oral E. purpurea supplementation in recreationally active males with above average aerobic fitness did not enhance EPO or erythropoietic status. These findings are in contrast with previous reports of E. purpurea supplementation in untrained participants with average fitness levels, but consistent with observations in trained endurance athletes.

Assessment of step accuracy using the Consumer Technology Association standard.

The purpose of this study was to compare the accuracy of commercially-available physical activity devices when walking and running at various treadmill speeds using CTA 2056: Physical Activity Monitoring for Fitness Wearables: Step Counting, standard by the Consumer Technology Association (CTA). Twenty participants (10 males and 10 females) completed self-paced walking and running protocols on the treadmill for five minutes each. Eight devices (Apple iWatch series 1, Fitbit Surge, Garmin 235, Moto 360, Polar A360, Suunto Spartan Sport, Suunto Spartan Trainer, and TomTom Spark 3) were tested two at a time, one per wrist. Manual step counts were obtained from video to serve as the benchmark. The mean absolute percent error (MAPE) was calculated during walking and running. During walking, three devices: Fitbit Surge (11.20%), Suunto Sport (22.93%), and TomTom (10.11%) and during running, one device, Polar (10.66%), exceeded the CTA suggestion of a MAPE < 10%. The Moto 360 had the lowest MAPE of all devices for both walking and running. The devices tested had higher step accuracy with running than walking, except for the Polar. Overall, the Apple iWatch series 1, Moto 360, Garmin, and Suunto Spartan Trainer met the CTA standard for both walking and running.

Sodium bicarbonate supplementation improves hypertrophy-type resistance exercise performance.

The aim of the present study was to examine the effects of sodium bicarbonate (NaHCO(3)) administration on lower-body, hypertrophy-type resistance exercise (HRE). Using a double-blind randomized counterbalanced design, 12 resistance-trained male participants (mean ± SD; age = 20.3 ± 2 years, mass = 88.3 ± 13.2 kg, height = 1.80 ± 0.07 m) ingested 0.3 g kg(-1) of NaHCO(3) or placebo 60 min before initiation of an HRE regimen. The protocol employed multiple exercises: squat, leg press, and knee extension, utilizing four sets each, with 10-12 repetition-maximum loads and short rest periods between sets. Exercise performance was determined by total repetitions generated during each exercise, total accumulated repetitions, and a performance test involving a fifth set of knee extensions to failure. Arterialized capillary blood was collected via fingertip puncture at four time points and analyzed for pH, [HCO(3)(-)], base excess (BE), and lactate [Lac(-)]. NaHCO(3) supplementation induced a significant alkaline state (pH: NaHCO(3): 7.49 ± 0.02, placebo: 7.42 ± 0.02, P < 0.05; [HCO(3)(-)]: NaHCO(3): 31.50 ± 2.59, placebo: 25.38 ± 1.78 mEq L(-1), P < 0.05; BE: NaHCO(3): 7.92 ± 2.57, placebo: 1.08 ± 2.11 mEq L(-1), P < 0.05). NaHCO(3) administration resulted in significantly more total repetitions than placebo (NaHCO(3): 139.8 ± 13.2, placebo: 134.4 ± 13.5), as well as significantly greater blood [Lac(-)] after the exercise protocol (NaHCO(3): 17.92 ± 2.08, placebo: 15.55 ± 2.50 mM, P < 0.05). These findings demonstrate ergogenic efficacy for NaHCO(3) during HRE and warrant further investigation into chronic training applications.

Running economy and maximal oxygen consumption after 4 weeks of oral Echinacea supplementation.

The purpose of this investigation was to determine the effects of 4 weeks of oral Echinacea (ECH) supplementation on erythropoietin (EPO), red blood cell (RBC) count, running economy (RE), and VO2max. Twenty-four men aged 24.9 ± 4.2 years, height 178.9 ± 7.9 cm, weight 87.9 ± 14.6 kg, body fat 19.3 ± 6.5% were grouped using a double-blind design and self-administered an 8,000-mg·d(-1) dosage of either ECH or placebo (PLA) in 5 × 400 mg × 4 times per day for 28 days. Blood samples were collected and analyzed for RBCs and EPO using automated flow cytometery and enzyme-linked immunosorbent assay. Maximal graded exercise tests (GXTs) were administered to measure VO2max, RE, and heart-rate responses. Analysis of variance was used to determine statistically significant differences (P ≤ 0.05). The EPO increased significantly in ECH at 7 days (ECH: 15.75 ± 0.64, PLA: 10.01 ± 0.73 mU·ml(-1)), 14 days (ECH: 18.88 ± 0.71, PLA: 11.02 ± 0.69 mU·ml(-1)), and 21 days (ECH: 16.06 ± 0.55, PLA: 9.20 ± 0.55 mU·ml(-1)). VO2max increased significantly in ECH (ECH: 1.47 ± 1.28, PLA: -0.13 ± 0.52%). Running economy improved significantly in ECH as indicated by a decrease in submaximal VO2max during the first 2 stages of the GXT (stage 1: ECH -1.50 ± 1.21, PLA 0.60 ± 1.95%; stage 2: ECH -1.67 ± 1.43, PLA 0.01 ± 1.03%). These data suggest that ECH supplementation results in significant increases in EPO, VO2max, and running economy.

The effect of 4 wk of oral echinacea supplementation on serum erythropoietin and indices of erythropoietic status.

The purpose of this investigation was to determine whether echinacea supplementation results in alterations of erythroid growth factors and erythropoietic status. Twenty-four men age 24.9 +/- 4.2 y, height 1.7 +/- 0.8 m, weight 87.9 +/- 14.6 kg, and 19.3% +/- 6.5% body fat were grouped using a double-blind design and self- administered an 8000-mg/d dose of either echinacea (ECH) or placebo (PLA) in 5 x 400 mg x 4 times/d for 28 d. Blood samples were collected and analyzed for red blood cells (RBCs), hematocrit (Hct), hemoglobin (Hb), mean corpuscular volume, mean corpuscular hemoglobin content, prostaglandin E2, ferritin, erythropoietin (EPO), interleukin 3 (IL-3), and granulocyte-macrophage-colony-stimulating factor using automated flow cytometry and ELISA. ANOVA was used to determine significant differences (P ? 0.05). EPO was greater (P < 0.001) in ECH at Days 7, 14, and 21 and reflected a 44%, 63%, and 36% increase, respectively. IL-3 was greater (P = 0.011) in ECH at Days 14 and 21, which indicated a 65% and 73% increase, respectively. These data indicate that ECH supplementation resulted in an increase in EPO and IL-3 but did not significantly alter RBCs, Hb, or Hct.

The effect of glycerol on torque, electromyography, and mechanomyography.

The purpose of this investigation was to determine the effect of hyperhydration on the electromyographic (EMG) and mechanomyographic (MMG) responses during isometric and isokinetic muscle actions of the biceps brachii. Eight (22.1 +/- 1.8 years, 79.5 +/- 22.8 kg) subjects were tested for maximal isometric, submaximal isometric, and maximal concentric isokinetic muscle strength in either a control (C) or hyperhydrated (H) state induced by glycerol ingestion while the EMG and MMG signals were recorded. Although fluid retention was significantly greater during the H protocol, the analyses indicated no change in torque, EMG amplitude, EMG mean power frequency (MPF), MMG amplitude, or MMG MPF with hyperhydration. These results indicated that glycerol-induced fluid retention does not affect the torque-producing capabilities of a muscle, the impulses (EMG) going to a muscle, or muscular vibrations (MMG). It has been suggested that EMG and MMG can be used as direct electrical/mechanical monitoring, which could be presented to trainers and athletes; however, before determining the utility of these signals, the MMG and EMG responses should be examined under a variety of conditions such as in the present study.

Effects of aerobic exercise on anxiety sensitivity.

Anxiety sensitivity is a known precursor to panic attacks and panic disorder, and involves the misinterpretation of anxiety-related sensations. Aerobic exercise has been shown to reduce generalized anxiety, and may also reduce anxiety sensitivity through exposure to feared physiological sensations. Accordingly, 54 participants with elevated anxiety sensitivity scores completed six 20-min treadmill exercise sessions at either a high-intensity aerobic ( n = 29 ) or low-intensity ( n = 25 ) level. Self-ratings of anxiety sensitivity, fear of physiological sensations associated with anxiety, and generalized anxiety were obtained at pre-treatment, post-treatment, and one-week follow-up. Results indicated that both high- and low-intensity exercise reduced anxiety sensitivity. However, high-intensity exercise caused more rapid reductions in a global measure of anxiety sensitivity and produced more treatment responders than low-intensity exercise. Only high-intensity exercise reduced fear of anxiety-related bodily sensations. The implications of these findings are discussed.

Comparison of glycerol and water hydration regimens on tennis-related performance.

PURPOSE: To compare glycerol and water hyperhydration and rehydration on tennis related skill and agility performance. METHODS: Eleven male subjects completed two counter-balanced, double-blind trials. Each trial consisted of three phases: 1). hyperhydration with or without glycerol (1.0 g.kg/(-1)) over 150 min, 2). 120 min of exercise-induced dehydration (EID), and 3) rehydration with or without glycerol (0.5 g.kg(-1)) over 90 min. After each phase, subjects performed 5- and 10-m sprint tests, a repeated-effort agility test, and tennis skill tests. RESULTS: Glycerol (G) hyperhydration significantly increased fluid retention by approximately 900 mL over the placebo (P) (P

Effect of moderate dehydration on torque, electromyography, and mechanomyography.

The purpose of the present investigation was to test the hypotheses that the mechanomyographic (MMG) signal would be affected by hydration status due to changes in the intra- and extracellular fluid content (which could affect the degree of fluid turbulence), changes in the filtering properties of the tissues between the MMG sensor and muscle, and changes in torque production that may accompany dehydration. Ten subjects (age 22.5 +/- 1.6 years) were tested for maximal isometric (MVC), submaximal isometric (25, 50, and 75%MVC), and maximal concentric isokinetic muscle strength of the biceps brachii in either a euhydrated or dehydrated state while the electromyographic (EMG) and MMG signals were recorded. Separate three-way and two-way ANOVAs indicated no change in torque, EMG amplitude, EMG mean power frequency (MPF), MMG amplitude, and MMG MPF with dehydration. The lack of dehydration effect suggests that MMG may be more reflective of the intrinsic contractile processes of a muscle fiber (torque production) or the motor control mechanisms (reflected by the EMG) than the tissues and fluids surrounding the muscle fiber.